FDA clears Abbott Alinity h-series hematology system

The Alinity h-series hematology system. [Image courtesy of Abbott]Abbott

(NYSE: ABT)
+
announced today that the FDA cleared its advanced Alinity h-series hematology system.
FDA clearance enables laboratories to run complete blood counts (CBCs) as part…

Source: www.massdevice.com – Read more